Product Information
LETROZOLE 2.5 MG TABLET is a generic product labeled by Accord Healthcare Inc., priced at $0.1535 per EA under NDC 16729003410. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
2.5 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729003410
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LETROZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA090934On Market Since
6/2/2011
Pharmacological Classes
Price Statistics
The NADAC for LETROZOLE 2.5 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 12.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1535 per EA |
|---|---|
| All-time high | $0.1962 (Feb 12, 2014) |
| All-time low | $0.1009 (Jun 21, 2023) |
| 52-week high | $0.1535 |
| 52-week low | $0.1292 |
| Median price | $0.1422 |
| Average price | $0.1454 |
| Largest weekly change | +32.3% (Nov 22, 2023) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LETROZOLE 2.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LETROZOLE 2.5 MG TABLET, manufactured by Accord Healthcare Inc., is $0.1535 per EA (NDC 16729003410), effective Jun 24, 2026.
How has the price of LETROZOLE 2.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for LETROZOLE 2.5 MG TABLET has declined 12.8%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LETROZOLE 2.5 MG TABLET?
Since Nov 28, 2013, the NADAC for LETROZOLE 2.5 MG TABLET has ranged from a low of $0.1009 (Jun 21, 2023) to a high of $0.1962 (Feb 12, 2014), with a median of $0.1422 per EA.
Are there cheaper alternatives to LETROZOLE 2.5 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as LETROZOLE 2.5 MG TABLET, but none are currently priced below it.
Who manufactures LETROZOLE 2.5 MG TABLET?
LETROZOLE 2.5 MG TABLET (NDC 16729003410) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification